BOSTON (AP) _ Paratek Pharmaceuticals Inc. (PRTK) on Wednesday reported a loss of $27.8 million in its first quarter.
The Boston-based company said it had a loss of 91 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 94 cents per share.
The pharmaceutical company posted revenue of $10,000 in the period.
Paratek shares have fallen 38 percent since the beginning of the year. The stock has declined 50 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTK at https://www.zacks.com/ap/PRTK